CNS Drugs Take Longer to Develop, Win Approval

Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials. 

Previous Flipbook
eCOA: Keep it Simple, Exec Argues
eCOA: Keep it Simple, Exec Argues

Nearly half of all clinical trials still use paper as the primary - or even sole - source of records while ...

Next Flipbook
Clinical Trials and Social Media - Friends or Foes?
Clinical Trials and Social Media - Friends or Foes?

Benchmark your study enrollment versus competitors

Get Benchmark Data